Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 10, Issue -, Pages 69-79
Publisher
Informa UK Limited
Online
2023-01-14
DOI
10.2147/jhc.s398632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators
- (2022) Kun Zhang et al. EUROPEAN RADIOLOGY
- Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A
- (2022) Yu Lei et al. Clinical and Translational Medicine
- Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization
- (2022) Sang Hyun Hwang et al. CLINICAL NUCLEAR MEDICINE
- Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
- (2022) Ke Su et al. Hepatology International
- Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study
- (2022) Ke Su et al. Hepatology International
- Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study
- (2022) Jin‐Xing Zhang et al. HEPATOLOGY RESEARCH
- Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
- (2022) Yu Jiang et al. Cancer Cell International
- Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
- (2022) Claudia Angela Maria Fulgenzi et al. EUROPEAN JOURNAL OF CANCER
- 177Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers
- (2022) Amir Karimzadeh et al. JOURNAL OF NUCLEAR MEDICINE
- PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study
- (2022) Ke Su et al. Frontiers in Immunology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Development of pre and post‐operative nomograms to predict individual survival for ideal liver resection candidates with hepatocellular carcinoma
- (2021) Jinshu Zeng et al. LIVER INTERNATIONAL
- Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma
- (2021) Yao Jun Zhang et al. JAMA Network Open
- Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease
- (2020) Somaya Hashem et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
- (2019) Ping Luo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma
- (2019) Hidetoshi Nitta et al. ANNALS OF SURGICAL ONCOLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer
- (2018) Tsutomu Namikawa et al. Gastric Cancer
- Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis
- (2018) Weihao Kong et al. Biomed Research International
- Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
- (2017) Vatche G. Agopian et al. JAMA Surgery
- Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection
- (2016) Si-Jia Wu et al. International Journal of Surgery
- The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma
- (2015) Xiao-li Wei et al. TUMOR BIOLOGY
- Biomarkers for the early diagnosis of hepatocellular carcinoma
- (2015) Nobuhiro Tsuchiya WORLD JOURNAL OF GASTROENTEROLOGY
- The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
- (2014) Luca Faloppi et al. BMC CANCER
- Alpha-fetoprotein: a renaissance
- (2013) A. A. Terentiev et al. TUMOR BIOLOGY
- Metabolic reprogramming of the tumor
- (2012) L M R Ferreira et al. ONCOGENE
- Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis
- (2011) X. Zha et al. CANCER RESEARCH
- Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition
- (2011) Kit-Ying Chung et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started